Evidence map›Paper›PMID 31915181›Full record

ArticleBMJ health & care informatics2020

Web-based decision-making tool for smoking cessation (Pare de fumar conosco) among patients with chronic conditions in Brazil : one-arm feasibility study.

Ana Paula Cupertino, Francisco Cartujano-Barrera, Fernando Antonio Basile Colugnati, Taynara Dutra Batista Formagini, Arise Garcia de Siqueira Galil, Eliane Ferreira Carvalho Banhato, Marilda Aparecida Ferreira, Kimber P Richter

Abstract read
In one paragraph

Article in BMJ health & care informatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Decídetexto: Feasibility and Acceptability of a Mobile Smoking Cessation Intervention in Puerto Rico.International journal of environmental research and public health · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana Paula CupertinoCancer Prevention and Control, Hackensack University Medical Center, Hackensack, New Jersey, USA Paula.Cupertino@hackensackmeridian.org.
Francisco Cartujano-BarreraCancer Prevention and Control, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Fernando Antonio Basile ColugnatiFaculdade de Medicina, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
Taynara Dutra Batista FormaginiDepartment of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, Kansas, USA.
Arise Garcia de Siqueira GalilFaculdade de Medicina, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
Eliane Ferreira Carvalho BanhatoFaculdade de Medicina, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
Marilda Aparecida FerreiraFundação Instituto Mineiro de Estudos e Pesquisas em Nefrologia, Juiz de Fora, Brazil.
Kimber P RichterDepartment of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, Kansas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the feasibility of Pare de fumar conosco, a web-based smoking cessation decision-making tool, among patients with chronic conditions in Brazil.

methodsWe recruited 85 Brazilian smokers in two clinical centres for chronic conditions to complete Pare de fumar conosco. Outcome measures included interest in using smoking cessation resources and self-reported 7-day point prevalence abstinence 12 weeks following the intervention.

resultsThe average age of participants was 54.2 years old (SD=10.5) and 77.9% had not completed high school. All participants were daily smokers and the majority smoked ≥11 cigarettes per day (63.5%). Pre-post intervention interest in using pharmacotherapy and group counselling significantly increased (82.4% vs 22.4%, p≤0.0001; and 85.9% vs 21.2%, p≤0.0001, respectively). At 12 weeks, eight participants (9.4%) reported 7-day point prevalence abstinence using intention-to-treat analysis (35.2% follow-up rate).

conclusionThe Pare de fumar conosco smoking cessation web-based tool significantly increased interest in pharmacotherapy and behavioural counselling. Additional testing as a formal randomised clinical trial appears warranted.

Indexed as

Chronic DiseaseDecision MakingInternetSmoking CessationAdultBrazilFeasibility StudiesFemaleHumansMaleMiddle AgedSelf ReportBrazileHealthglobal healthsmokingsmoking cessation

Identifiers

PMID31915181
PMCPMC7062353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.